CRGM is the U.S. subsidiary of China Renaissance, a leading Asia-based financial institution founded in 2005. From New York, we deliver equity capital markets execution, M&A advisory, sales & trading, and research for companies and institutional investors navigating the world's two largest economies.
CRGM operates as the United States platform of China Renaissance (HKEX: 1911), a Main Board–listed financial institution with offices in Beijing, Shanghai, Hong Kong, New York and Singapore. For more than two decades, the Group's financial advisory franchise has maintained market leadership among new-economy issuers, with deep coverage of artificial intelligence, hard technology, healthcare and consumer sectors.
From New York, CRGM provides capital and liquidity solutions across the corporate lifecycle: equity capital markets, M&A advisory, biotech licensing, private placements, corporate strategy, equity research, and sales & trading. Licensed in the United States since 2013, we serve as underwriter, placement agent and advisor to private and public companies alike.
One firm. Every resource. Behind every client.
Every engagement is supported by the Group's integrated cross-border investment banking platform and on-the-ground teams across Asia and the United States.
Advising global issuers on U.S. IPOs, ADR programs, follow-on offerings, CMPO, ATM, and direct listings. Supporting execution across NASDAQ and NYSE transactions, from pre-IPO positioning through aftermarket.
Providing buy-side and sell-side advisory for strategic and financial counterparties, with particular depth in transactions that cross U.S. and global regulatory, tax and governance frameworks.
Advising growth-stage and pre-IPO companies on private capital raising, drawing on an advisory franchise with extensive experience in Asia's primary financing markets, and on long‑standing relationships with global crossover investors.
Connecting U.S. investors with U.S. and Asia-listed equities through institutional distribution and trading, supported by the Group's global execution platforms.
Covering global new economy companies through independent research, supported by deep sector expertise and long-standing market relationships.
Providing strategic counsel for boards and founders on listing venue selection, dual-entity structures, regulatory coordination across the SEC, HKEX, CSRC and other frameworks, and U.S. market entry.
Foundation models, AI infrastructure and applications, where the Group provided financial advisory services and was noted for its expertise.
Covering semiconductors, robotics, advanced manufacturing and new energy, where the Group was recognized as a leading financial advisor in the new energy sector.
Biotech, medtech and healthcare services, spanning clinical-stage capital formation through cross-border licensing and public listings.
The platforms, brands and technology-enabled services that have defined the Group's franchise since 2005.
Selected developments across the China Renaissance Group and its U.S. platform.
Loading updates...
More than 400 professionals across five offices, operating under securities licenses in Hong Kong (2012), the United States (2013), Mainland China (2016) and Singapore (2022). For clients, that means one relationship with genuine, regulated execution capability on both sides of the Pacific.
ECM execution, M&A advisory, institutional sales and cross-border coverage for the Americas.
Investment banking, sales & trading, research and wealth management under SFC licensing.
Advisory franchise leadership and CR Securities' full-license domestic platform.
Coverage of the Yangtze Delta technology and healthcare ecosystems.
Capital Markets Services–licensed platform serving Southeast Asia's growth corridor.
Create lasting value for our clients.
Commit to delivering quality service and value in every business we operate.
Choose long-term potential over short-term gains.
Treat every client as unique and put clients first.
Work as one firm and mobilize resources across the platform.
Protect our reputation through discipline and integrity.
We look for professionals with genuine fluency across markets, languages and regulatory frameworks — and the entrepreneurship to build a franchise, not just work at one.
View Open PositionsWhether you are a board evaluating a U.S. listing, a founder raising pre-IPO capital, or an institution seeking differentiated access to Asia's growth companies, our team is ready to help.
295 Madison Avenue Suite 1830
New York, NY 10017, USA